ResMed Statistics

Total Valuation

ResMed has a market cap or net worth of MXN 680.33 billion. The enterprise value is 670.56 billion.

Market Cap	680.33B
Enterprise Value	670.56B

Important Dates

The next estimated earnings date is Thursday, January 22, 2026.

Earnings Date	Jan 22, 2026
Ex-Dividend Date	Nov 13, 2025

Share Statistics

Current Share Class	145.91M
Shares Outstanding	n/a
Shares Change (YoY)	-0.28%
Shares Change (QoQ)	-0.09%
Owned by Insiders (%)	0.53%
Owned by Institutions (%)	69.03%
Float	144.84M

Valuation Ratios

The trailing PE ratio is 25.80 and the forward PE ratio is 22.94.

PE Ratio	25.80
Forward PE	22.94
PS Ratio	7.06
PB Ratio	6.06
P/TBV Ratio	14.10
P/FCF Ratio	20.97
P/OCF Ratio	19.69
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.60, with an EV/FCF ratio of 20.67.

EV / Earnings	25.42
EV / Sales	7.01
EV / EBITDA	18.60
EV / EBIT	20.86
EV / FCF	20.67

Financial Position

The company has a current ratio of 2.89, with a Debt / Equity ratio of 0.14.

Current Ratio	2.89
Quick Ratio	1.87
Debt / Equity	0.14
Debt / EBITDA	0.43
Debt / FCF	0.48
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 25.41% and return on invested capital (ROIC) is 16.93%.

Return on Equity (ROE)	25.41%
Return on Assets (ROA)	14.18%
Return on Invested Capital (ROIC)	16.93%
Return on Capital Employed (ROCE)	24.99%
Revenue Per Employee	9.10M
Profits Per Employee	2.49M
Employee Count	10,600
Asset Turnover	0.68
Inventory Turnover	2.03

Taxes

In the past 12 months, ResMed has paid 5.56 billion in taxes.

Income Tax	5.56B
Effective Tax Rate	17.40%

Stock Price Statistics

The stock price has increased by +33.47% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+33.47%
50-Day Moving Average	4,406.98
200-Day Moving Average	n/a
Relative Strength Index (RSI)	59.28
Average Volume (20 Days)	395

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	10.34

Income Statement

In the last 12 months, ResMed had revenue of MXN 96.43 billion and earned 26.37 billion in profits. Earnings per share was 179.22.

Revenue	96.43B
Gross Profit	58.53B
Operating Income	32.33B
Pretax Income	31.93B
Net Income	26.37B
EBITDA	35.56B
EBIT	32.33B
Earnings Per Share (EPS)	179.22

Full Income Statement

Balance Sheet

The company has 25.38 billion in cash and 15.52 billion in debt, giving a net cash position of 9.86 billion.

Cash & Cash Equivalents	25.38B
Total Debt	15.52B
Net Cash	9.86B
Net Cash Per Share	n/a
Equity (Book Value)	112.28B
Book Value Per Share	769.33
Working Capital	43.48B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 34.55 billion and capital expenditures -2.11 billion, giving a free cash flow of 32.44 billion.

Operating Cash Flow	34.55B
Capital Expenditures	-2.11B
Free Cash Flow	32.44B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 60.69%, with operating and profit margins of 33.52% and 27.35%.

Gross Margin	60.69%
Operating Margin	33.52%
Pretax Margin	33.11%
Profit Margin	27.35%
EBITDA Margin	36.87%
EBIT Margin	33.52%
FCF Margin	33.64%

Dividends & Yields

This stock pays an annual dividend of 43.42, which amounts to a dividend yield of 0.85%.

Dividend Per Share	43.42
Dividend Yield	0.85%
Dividend Growth (YoY)	17.30%
Years of Dividend Growth	1
Payout Ratio	22.31%
Buyback Yield	0.28%
Shareholder Yield	1.13%
Earnings Yield	3.88%
FCF Yield	4.77%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ResMed has an Altman Z-Score of 12.67 and a Piotroski F-Score of 6.

Altman Z-Score	12.67
Piotroski F-Score	6